- Page 2 and 3:
Molecular Medical Parasitology
- Page 4 and 5:
Molecular Medical Parasitology Edit
- Page 6 and 7:
Contents List of contributors Prefa
- Page 8 and 9:
List of contributors Mark Blaxter,
- Page 10 and 11:
LIST OF CONTRIBUTORS ix Richard. J.
- Page 12 and 13:
Preface Parasitology was born as th
- Page 14 and 15:
S E C T I O N I MOLECULAR BIOLOGY
- Page 16 and 17:
C H A P T E R 1 Parasite genomics M
- Page 18 and 19:
TABLE 1.1 Parasite genomes: genome
- Page 20 and 21:
GENERATING GENOMICS DATA 7 differen
- Page 22 and 23:
GENERATING GENOMICS DATA 9 TABLE 1.
- Page 24 and 25:
GENERATING GENOMICS DATA 11 called
- Page 26 and 27:
GENERATING GENOMICS DATA 13 200 000
- Page 28 and 29:
BIOINFORMATICS AND THE ANALYSIS OF
- Page 30 and 31:
THE POST-GENOMICS ERA, AND THE OTHE
- Page 32 and 33:
THE PARASITES AND THEIR GENOMES 19
- Page 34 and 35:
THE PARASITES AND THEIR GENOMES 21
- Page 36 and 37:
THE PARASITES AND THEIR GENOMES 23
- Page 38 and 39:
THE PARASITES AND THEIR GENOMES 25
- Page 40 and 41:
FURTHER READING 27 treated with a d
- Page 42 and 43:
C H A P T E R 2 RNA processing in p
- Page 44 and 45:
TRANS-SPLICING 31 cis trans Exon 1
- Page 46 and 47:
TRANS-SPLICING 33 snRNPs (small nuc
- Page 48 and 49:
TRANS-SPLICING 35 trans cis U2AF35
- Page 50 and 51:
RNA EDITING 37 P AAAA... AAAA... AA
- Page 52 and 53:
RNA EDITING 39 entire transcript re
- Page 54 and 55:
RNA EDITING 41 5 Editing block C Ed
- Page 56 and 57:
RNA EDITING 43 microscopy) approach
- Page 58 and 59:
FURTHER READING 45 Nilsen, T.W. (19
- Page 60 and 61:
C H A P T E R 3 Transcription Arthu
- Page 62 and 63:
UNUSUAL MODES OF TRANSCRIPTION IN T
- Page 64 and 65:
CLASS I TRANSCRIPTION IN TRYPANOSOM
- Page 66 and 67:
CLASS I TRANSCRIPTION IN TRYPANOSOM
- Page 68 and 69:
CLASS I TRANSCRIPTION IN TRYPANOSOM
- Page 70 and 71:
CLASS II TRANSCRIPTION OF PROTEIN C
- Page 72 and 73:
SL RNA AND U snRNA GENE TRANSCRIPTI
- Page 74 and 75:
SL RNA AND U snRNA GENE TRANSCRIPTI
- Page 76 and 77:
SL RNA AND U snRNA GENE TRANSCRIPTI
- Page 78 and 79:
FURTHER READING 65 and switching in
- Page 80 and 81:
C H A P T E R 4 Post-transcriptiona
- Page 82 and 83:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 84 and 85:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 86 and 87:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 88 and 89:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 90 and 91:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 92 and 93:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 94 and 95:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 96 and 97:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 98 and 99:
POST-TRANSCRIPTIONAL REGULATION IN
- Page 100 and 101:
FURTHER READING 87 inhibition, it m
- Page 102 and 103:
C H A P T E R 5 Antigenic variation
- Page 104 and 105:
ANTIGENIC VARIATION AT THE STRUCTUR
- Page 106 and 107:
ANTIGENIC VARIATION AT THE STRUCTUR
- Page 108 and 109:
VSG Signal sequence Amino-terminal
- Page 110 and 111:
GENETICS OF ANTIGENIC VARIATION 97
- Page 112 and 113:
GENETICS OF ANTIGENIC VARIATION 99
- Page 114 and 115:
GENETICS OF ANTIGENIC VARIATION 101
- Page 116 and 117:
IMMUNE RESPONSES TO TRYPANOSOME INF
- Page 118 and 119: INNATE RESISTANCE, HUMAN SUSCEPTIBI
- Page 120 and 121: ANTIGENIC VARIATION IN MALARIA 107
- Page 122 and 123: FURTHER READING 109 ACKNOWLEDGEMENT
- Page 124 and 125: C H A P T E R 6 Genetic and genomic
- Page 126 and 127: ‘FORWARD’ VS. ‘REVERSE’ GEN
- Page 128 and 129: EXAMPLES OF ‘FORWARD’ GENETIC A
- Page 130 and 131: EXAMPLES OF ‘FORWARD’ GENETIC A
- Page 132 and 133: REVERSE GENETICS AND LEISHMANIA VIR
- Page 134 and 135: VALIDATION OF CANDIDATE VIRULENCE G
- Page 136 and 137: S E C T I O N II BIOCHEMISTRY AND C
- Page 138 and 139: C H A P T E R 7 Energy metabolism P
- Page 140 and 141: SUBCELLULAR ORGANIZATION OF AMITOCH
- Page 142 and 143: CELL MEMBRANE Fructose [b] Glucose
- Page 144 and 145: STEPS OF AMITOCHONDRIATE CORE METAB
- Page 146 and 147: ENZYMATIC DIFFERENCES BETWEEN AMITO
- Page 148 and 149: ACTION OF NITROIMIDAZOLE DRUGS 135
- Page 150 and 151: ENVOI 137 unambiguously reflect the
- Page 152 and 153: FURTHER READING 139 Saavedra-Lira,
- Page 154 and 155: THE EMBDEN-MEYERHOF-PARNAS (EMP) PA
- Page 156 and 157: THE EMBDEN-MEYERHOF-PARNAS (EMP) PA
- Page 158 and 159: THE EMBDEN-MEYERHOF-PARNAS (EMP) PA
- Page 160 and 161: THE EMBDEN-MEYERHOF-PARNAS (EMP) PA
- Page 162 and 163: THE EMBDEN-MEYERHOF-PARNAS (EMP) PA
- Page 164 and 165: WHY DO TRYPANOSOMATIDAE HAVE GLYCOS
- Page 166 and 167: FURTHER READING 153 for use in agri
- Page 170 and 171: CARBOHYDRATE METABOLISM 157 essenti
- Page 172 and 173: CARBOHYDRATE METABOLISM 159 assesse
- Page 174 and 175: MITOCHONDRIAL METABOLISM 161 Plasmo
- Page 176 and 177: MITOCHONDRIAL METABOLISM 163 sensit
- Page 178 and 179: DEVELOPMENTAL VARIATION AND CARBOHY
- Page 180 and 181: DEVELOPMENTAL VARIATION AND CARBOHY
- Page 182 and 183: FURTHER READING 169 of P. falciparu
- Page 184 and 185: C H A P T E R 8 Amino acid and prot
- Page 186 and 187: AMINO ACID SOURCES 173 as pentamidi
- Page 188 and 189: AMINO ACID SOURCES 175 from T. rang
- Page 190 and 191: AMINO ACID SOURCES 177 have been th
- Page 192 and 193: AMINO ACID SOURCES 179 matrix prote
- Page 194 and 195: AMINO ACID SOURCES 181 proteinases
- Page 196 and 197: AMINO ACID METABOLISM 183 appears t
- Page 198 and 199: AMINO ACID METABOLISM 185 Glutamine
- Page 200 and 201: AMINO ACID METABOLISM 187 α-ketobu
- Page 202 and 203: AMINO ACID METABOLISM 189 Glu NH 3
- Page 204 and 205: AMINO ACID METABOLISM 191 Methionin
- Page 206 and 207: AMINO ACID METABOLISM 193 GTP (1) F
- Page 208 and 209: FURTHER READING 195 Amino acid cata
- Page 210 and 211: C H A P T E R 9 Purine and pyrimidi
- Page 212 and 213: INTRODUCTION 199 TABLE 9.1 Purine a
- Page 214 and 215: TRANSPORT SYSTEMS 201 to be discove
- Page 216 and 217: TRANSPORT SYSTEMS 203 adenine. Like
- Page 218 and 219:
TRANSPORT SYSTEMS 205 forms of the
- Page 220 and 221:
PURINE METABOLISM 207 nucleobases a
- Page 222 and 223:
PURINE METABOLISM 209 purine availa
- Page 224 and 225:
PURINE METABOLISM 211 is not curren
- Page 226 and 227:
PURINE METABOLISM 213 FIGURE 9.6 Ki
- Page 228 and 229:
PURINE METABOLISM 215 specificities
- Page 230 and 231:
PURINE METABOLISM 217 FIGURE 9.8 Tr
- Page 232 and 233:
PYRIMIDINES 219 Thymidine Uridine D
- Page 234 and 235:
PYRIMIDINES 221 activities have bee
- Page 236 and 237:
FURTHER READING 223 ACKNOWLEDGMENTS
- Page 238 and 239:
C H A P T E R 10 Trypanosomatid sur
- Page 240 and 241:
AFRICAN TRYPANOSOMES 227 VSG Procyc
- Page 242 and 243:
TRYPANOSOMA CRUZI 229 Mucins GIPLs
- Page 244 and 245:
LEISHMANIA 231 (1,6)myo-inositol-1-
- Page 246 and 247:
LEISHMANIA 233 -Glc, and the L. tro
- Page 248 and 249:
LEISHMANIA 235 knockouts (either LP
- Page 250 and 251:
LEISHMANIA 237 Membrane-bound acid
- Page 252 and 253:
CRITHIDIA 239 cap structures. Inter
- Page 254 and 255:
C H A P T E R 11 Intracellular sign
- Page 256 and 257:
CALCIUM 243 forms of Trypanosoma br
- Page 258 and 259:
CALCIUM 245 parasites. Organisms su
- Page 260 and 261:
CALCIUM 247 on sequence homologies.
- Page 262 and 263:
CALCIUM 249 acidocalcisome. The aci
- Page 264 and 265:
CALCIUM 251 Similar results are obt
- Page 266 and 267:
CALCIUM 253 (A) EF-hand structure (
- Page 268 and 269:
CALCIUM 255 towards establishing th
- Page 270 and 271:
CYCLIC NUCLEOTIDES 257 The structur
- Page 272 and 273:
CYCLIC NUCLEOTIDES 259 also occur i
- Page 274 and 275:
CYCLIC NUCLEOTIDES 261 Other enzymi
- Page 276 and 277:
CYCLIC NUCLEOTIDES 263 Plasmodium g
- Page 278 and 279:
REVERSIBLE PROTEIN PHOSPHORYLATION
- Page 280 and 281:
REVERSIBLE PROTEIN PHOSPHORYLATION
- Page 282 and 283:
REVERSIBLE PROTEIN PHOSPHORYLATION
- Page 284 and 285:
REVERSIBLE PROTEIN PHOSPHORYLATION
- Page 286 and 287:
REVERSIBLE PROTEIN PHOSPHORYLATION
- Page 288 and 289:
FURTHER READING 275 nature of the p
- Page 290 and 291:
C H A P T E R 12 Plastids, mitochon
- Page 292 and 293:
MITOCHONDRIAL REDUCTION 279 amino a
- Page 294 and 295:
MITOCHONDRIAL METABOLISM 281 Cofact
- Page 296 and 297:
‘AMITOCHONDRIATE’ ORGANISMS 283
- Page 298 and 299:
A NEW HYPOTHESIS 285 How does the h
- Page 300 and 301:
PLASTIDS 287 the domain of botany a
- Page 302 and 303:
PLASTIDS 289 Further sequence data
- Page 304 and 305:
PLASTIDS 291 recently trees incorpo
- Page 306 and 307:
ACKNOWLEDGMENT 293 humans; babesios
- Page 308 and 309:
S E C T I O N III BIOCHEMISTRY AND
- Page 310 and 311:
C H A P T E R 13 Helminth surfaces:
- Page 312 and 313:
CESTODES 299 material bounded by th
- Page 314 and 315:
CESTODES 301 Cestodes have at least
- Page 316 and 317:
TREMATODES 303 cavity (gastrodermis
- Page 318 and 319:
TREMATODES 305 glucose, galactose,
- Page 320 and 321:
TREMATODES 307 Two schistosome gluc
- Page 322 and 323:
TREMATODES 309 Recent evidence sugg
- Page 324 and 325:
NEMATODES 311 block the actions of
- Page 326 and 327:
NEMATODES 313 the epicuticle is the
- Page 328 and 329:
NEMATODES 315 Most tissue in the un
- Page 330 and 331:
NEMATODES 317 Functional biology Bi
- Page 332 and 333:
NEMATODES 319 energy-independent io
- Page 334 and 335:
NEMATODES 321 high-affinity binding
- Page 336 and 337:
NEMATODES 323 regulation in C. eleg
- Page 338 and 339:
NEMATODES 325 a vacuolar-type H -A
- Page 340 and 341:
NEMATODES 327 The transcuticular ex
- Page 342 and 343:
NEMATODES 329 elaborated by microvi
- Page 344 and 345:
NEMATODES 331 animal-parasitic nema
- Page 346 and 347:
NEMATODES 333 pharynx at the end of
- Page 348 and 349:
NEMATODES 335 obtain samples for an
- Page 350 and 351:
FURTHER READING 337 Also, a mutatio
- Page 352 and 353:
C H A P T E R 14 Carbohydrate and e
- Page 354 and 355:
GLYCOLYSIS 341 fluctuate between pe
- Page 356 and 357:
GLYCOLYSIS 343 ethanol; it is in re
- Page 358 and 359:
MITOCHONDRIAL METABOLISM AND ENERGY
- Page 360 and 361:
MITOCHONDRIAL METABOLISM AND ENERGY
- Page 362 and 363:
MITOCHONDRIAL METABOLISM AND ENERGY
- Page 364 and 365:
MITOCHONDRIAL METABOLISM AND ENERGY
- Page 366 and 367:
THE AEROBIC/ANAEROBIC TRANSITION DU
- Page 368 and 369:
FURTHER READING 355 identified, fro
- Page 370 and 371:
FURTHER READING 357 Komuniecki, R.
- Page 372 and 373:
C H A P T E R 15 Neurotransmitters
- Page 374 and 375:
NEUROTRANSMITTERS IN NEMATODES 361
- Page 376 and 377:
NEUROTRANSMITTERS IN NEMATODES 363
- Page 378 and 379:
NEUROTRANSMITTERS IN NEMATODES 365
- Page 380 and 381:
NEUROTRANSMITTERS IN NEMATODES 367
- Page 382 and 383:
NEUROTRANSMITTERS IN NEMATODES 369
- Page 384 and 385:
NEUROTRANSMITTERS IN NEMATODES 371
- Page 386 and 387:
NEUROTRANSMITTERS IN NEMATODES 373
- Page 388 and 389:
NEUROTRANSMITTERS IN NEMATODES 375
- Page 390 and 391:
NEUROTRANSMITTERS IN NEMATODES 377
- Page 392 and 393:
NEUROTRANSMITTERS IN NEMATODES 379
- Page 394 and 395:
NEUROTRANSMITTERS IN NEMATODES 381
- Page 396 and 397:
NEUROTRANSMITTERS IN NEMATODES 383
- Page 398 and 399:
NEUROTRANSMITTERS IN PLATYHELMINTHS
- Page 400 and 401:
NEUROTRANSMITTERS IN PLATYHELMINTHS
- Page 402 and 403:
NEUROTRANSMITTERS IN PLATYHELMINTHS
- Page 404 and 405:
NEUROTRANSMITTERS IN PLATYHELMINTHS
- Page 406 and 407:
FURTHER READING 393 that is forced
- Page 408 and 409:
S E C T I O N IV MEDICAL APPLICATIO
- Page 410 and 411:
C H A P T E R 16 Drug resistance in
- Page 412 and 413:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 414 and 415:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 416 and 417:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 418 and 419:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 420 and 421:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 422 and 423:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 424 and 425:
DRUG RESISTANCE IN APICOMPLEXAN PAR
- Page 426 and 427:
DRUG RESISTANCE IN KINETOPLASTID PA
- Page 428 and 429:
DRUG RESISTANCE IN KINETOPLASTID PA
- Page 430 and 431:
DRUG RESISTANCE IN KINETOPLASTID PA
- Page 432 and 433:
DRUG RESISTANCE IN KINETOPLASTID PA
- Page 434 and 435:
DRUG RESISTANCE IN KINETOPLASTID PA
- Page 436 and 437:
DRUG RESISTANCE IN ANAEROBIC PARASI
- Page 438 and 439:
DRUG RESISTANCE IN ANAEROBIC PARASI
- Page 440 and 441:
HELMINTHS AND CHEMOTHERAPY 427 FIGU
- Page 442 and 443:
CLINICAL IMPLICATIONS AND OUTLOOK 4
- Page 444 and 445:
FURTHER READING 431 analysis, which
- Page 446 and 447:
C H A P T E R 17 Medical implicatio
- Page 448 and 449:
BACKGROUND 435 TABLE 17.1 (Continue
- Page 450 and 451:
PRINCIPLES OF ANTIPARASITIC CHEMOTH
- Page 452 and 453:
TREATMENT OF PARASITIC DISEASES 439
- Page 454 and 455:
TREATMENT OF PARASITIC DISEASES 441
- Page 456 and 457:
TREATMENT OF PARASITIC DISEASES 443
- Page 458 and 459:
TREATMENT OF PARASITIC DISEASES 445
- Page 460 and 461:
TREATMENT OF PARASITIC DISEASES 447
- Page 462 and 463:
TREATMENT OF PARASITIC DISEASES 449
- Page 464 and 465:
TREATMENT OF PARASITIC DISEASES 451
- Page 466 and 467:
TREATMENT OF PARASITIC DISEASES 453
- Page 468 and 469:
TREATMENT OF PARASITIC DISEASES 455
- Page 470 and 471:
TREATMENT OF PARASITIC DISEASES 457
- Page 472 and 473:
TREATMENT OF PARASITIC DISEASES 459
- Page 474 and 475:
FURTHER READING 461 The excitement
- Page 476 and 477:
Index A2, 119 ABC transporters, dru
- Page 478 and 479:
INDEX 465 Apicomplexans, 437 drug r
- Page 480 and 481:
INDEX 467 cell functions, 255-6 hom
- Page 482 and 483:
INDEX 469 Diminazene aceturate (Ber
- Page 484 and 485:
INDEX 471 Fluorescence-activated ce
- Page 486 and 487:
INDEX 473 Halofantrine: resistance,
- Page 488 and 489:
INDEX 475 energy metabolism, 145 ge
- Page 490 and 491:
INDEX 477 Mosquito vectors, 26 MSPL
- Page 492 and 493:
INDEX 479 PfATP 6, 246 PfCDPK1, 253
- Page 494 and 495:
INDEX 481 Procyclin genes: expressi
- Page 496 and 497:
INDEX 483 Sarcoptes scabei: chemoth
- Page 498 and 499:
INDEX 485 Transcription factors, 48
- Page 500 and 501:
INDEX 487 Trypanosoma equiperdum, 9